The emerging role of MRI in the diagnosis and management of cardiomyopathies

Current Cardiology Reports

Volumn 8, Issue 1, 2006, Pages 44-52

  Rochitte, Carlos Eduardo ^a   Tassi, Eduardo Marinho ^b   Shiozaki, Afonso Akio ^b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOIDOSIS; CARDIOMYOPATHY; CHAGAS DISEASE; COLLAGEN DISEASE; CONGESTIVE CARDIOMYOPATHY; DIAGNOSTIC ACCURACY; HEART FUNCTION; HEART MUSCLE; HEART MUSCLE FIBROSIS; HEART RIGHT VENTRICLE DYSPLASIA; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MYOCARDITIS; NON INVASIVE PROCEDURE; NUCLEAR MAGNETIC RESONANCE IMAGING; PROGNOSIS; RESTRICTIVE CARDIOMYOPATHY; REVIEW; SARCOIDOSIS; TISSUE CHARACTERIZATION;

ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA; CARDIOMYOPATHIES; HUMANS; MAGNETIC RESONANCE IMAGING; MYOCARDIUM;

EID: 33645079656     PISSN: 15233782     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11886-006-0010-5     Document Type: Review

References (71)

1. Richardson P, McKenna W, Bristow M, et al.: Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. Circulation 1996, 93:841-842.
2. Pennell DJ, Sechtem UP, Higgins CB, et al.: Clinical indications for cardiovascular magnetic resonance (CMR): consensus panel report. Eur Heart J 2004, 25:1940-1965.
3. Wagner A, Mahrholdt H, Holly TA, et al.: Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study. Lancet 2003, 361:374-379.
4. Heusch A, Koch JA, Krogmann ON, et al.: Volumetric analysis of the right and left ventricle in a porcine heart model: comparison of three-dimensional echocardiography, magnetic resonance imaging and angiocardiography. Eur J Ultrasound 1999, 9:245-255.
5. Bellenger NG, Francis JM, Davies CL, et al.: Establishment and performance of a magnetic resonance cardiac function clinic. J Cardiovasc Magn Reson 2000, 2:15-22.
6. Rajappan K, Bellenger NC, Anderson L, Pennell DJ: The role of cardiovascular magnetic resonance in heart failure. Eur J Heart Fail 2000, 2:241-252.
7. Kim RJ, Fieno DS, Parrish TB, et al.: Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 1999, 100:1992-2002.
8. Rochitte CE, Lima JA, Bluemke DA, et al.: Magnitude and time course of microvascular obstruction and tissue injury after acute myocardial infarction. Circulation 1998, 98:1006-1014.
9. Kim RJ, Wu E, Rafael A, et al.: The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000, 343:1445-1453.
10. McCrohon JA, Moon JC, Prasad SK, et al.: Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation 2003, 108:54-59.
11. Maron BJ, McKenna WJ, Danielson GK, et al.: American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. Eur Heart J 2003, 24:1965-1991.
12. Wu KG, Heldman AW, Brinker JA, et al.: Microvascular obstruction after nonsurgical septal reduction for the treatment of hypertrophic cardiomyopathy. Circulation 2001, 104:1868.
13. Myerson SG, Bellenger NG, Pennell DJ: Assessment of left ventricular mass by cardiovascular magnetic resonance. Hypertension 2002, 39:750-755.
14. Petersen SE, Selvanayagam JB, Francis JM, et al.: Differentiation of athlete's heart from pathological forms of cardiac hypertrophy by means of geometric indices derived from cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2005, 7:551-558.
15. Choudhury L, Mahrholdt H, Wagner A, et al.: Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 2002, 40:2156-2164.
16. Kuribayashi T, Roberts WG: Myocardial disarray at junction of ventricular septum and left and right ventricular free walls in hypertrophic cardiomyopathy. Am J Cardiol 1992, 70:1333-1340.
17. Amano Y, Kumita S, Takayama M, Kumazaki T: Comparison of Contrast-Enhanced MRI with Iodine-123 BMIPP for Detection of Myocardial Damage in Hypertrophic Cardiomyopathy. AJR Am J Roentgenol 2005, 185:312-318.
18. Moon JC, Reed E, Sheppard MN, et al.: The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Am Coll Cardiol 2004, 43:2260-2264.
19. Moon JC, McKenna WJ, McCrohon JA, et al.: Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. J Am Coll Cardiol 2003, 41:1561-1567.
20. Masui T, Finck S, Higgins CB: Constrictive pericarditis and restrictive cardiomyopathy: evaluation with MR imaging. Radiology 1992, 182:369-373.
21. Hancock EW: Differential diagnosis of restrictive cardiomyopathy and constrictive pericarditis. Heart 2001, 86:343-349.
22. Fattori R, Rocchi G, Celletti F, et al.: Contribution of magnetic resonance imaging in the differential diagnosis of cardiac amyloidosis and symmetric hypertrophic cardiomyopathy. Am Heart J 1998, 136:824-830.
23. Celletti F, Fattori R, Napoli G, et al.: Assessment of restrictive cardiomyopathy of amyloid or idiopathic etiology by magnetic resonance imaging. Am J Cardiol 1999, 83:798-801, A10.
24. Mahrholdt H, Wagner A, Judd RM, et al.: Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies. Eur Heart J 2005, 26:1461-1474.
25. Parrillo JE: Heart disease and the eosinophil. N Engl J Med 1990, 323:1560-1561.
26. Salemi VMC, Rochitte CE, Almeida SA, et al.: Usefulness of myocardial delayed enhancement magnetic resonance in the diagnosis and surgical treatment of endomyocardial fibrosis [abstract]. J Am Coll Cardiol 2004, 43:366A.
27. Brittenham GM, Badman DG: Noninvasive measurement of iron: report of an NIDDK workshop. Blood 2003, 101:15-19.
28. Johnston DL, Rice L, Vick GW, III, et al.: Assessment of tissue iron overload by nuclear magnetic resonance imaging. Am J Med 1989, 87:40-47.
29. Anderson LJ, Holden S, Davis B, et al.: Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J 2001, 22:2171-2179.
30. Wood JC, Otto-Duessel M, Aguilar M, et al.: Cardiac iron determines cardiac T2*, T2, and T1 in the gerbil model of iron cardiomyopathy. Circulation 2005, 112:535-543.
31. Kinney TB, Deluca SA: Idiopathic hemochromatosis. Am Fam Physician 1991, 44:873-875.
32. Ptaszek LM, Price ET, Hu MY, Yang PC: Early diagnosis of hemochromatosis-related cardiomyopathy with magnetic resonance imaging. J Cardiovasc Magn Reson 2005, 7:689-692.
33. Waxman S, Eustace S, Hartnell GG: Myocardial involvement in primary hemochromatosis demonstrated by magnetic resonance imaging. Am Heart J 1994, 128:1047-1049.
34. Johnston DL: Myocardial tissue characterization with magnetic resonance imaging techniques. Am J Card Imaging 1994, 8:140-150.
35. Jensen PD, Bagger JP, Jensen FT, et al.: Heart transplantation in a case of juvenile hereditary haemochromatosis followed up by MRI and endomyocardial biopsies. Eur J Haematol 1993, 51:199-205.
36. Marcus F, Towbin JA, Zareba W, et al.: Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C): a multidisciplinary study: design and protocol. Circulation 2003, 107:2975-2978.
37. Tandri H, Bomma C, Calkins H, Bluemke DA: Magnetic resonance and computed tomography imaging of arrhythmogenic right ventricular dysplasia. J Magn Reson Imaging 2004, 19:848-858.
38. Kayser HW, van der Wall EE, Sivananthan MU, et al.: Diagnosis of arrhythmogenic right ventricular dysplasia: a review. Radiographics 2002, 22:639-648.
39. Menghetti L, Basso C, Nava A, et al.: Spin-echo nuclear magnetic resonance for tissue characterisation in arrhythmogenic right ventricular cardiomyopathy. Heart 1996, 76:467-470.
40. Bluemke DA, Krupinski EA, Ovitt T, et al.: MR imaging of arrhythmogenic right ventricular cardiomyopathy: morphologic findings and interobserver reliability. Cardiology 2003, 99:153-162.
41. Bomma C, Dalal D, Tandri H, et al.: Regional differences in systolic and diastolic function in arrhythmogenic right ventricular dysplasia/ cardiomyopathy using magnetic resonance imaging. Am J Cardiol 2005, 95:1507-1511.
42. Tandri H, Saranathan M, Rodriguez ER, et al.: Noninvasive detection of myocardial fibrosis in arrhythmogenic right ventricular cardiomyopathy using delayed-enhancement magnetic resonance imaging. J Am Coll Cardiol 2005, 45:98-103.
43. Kawai C: From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death: learning from the past for the future. Circulation 1999, 99:1091-1100.
44. Friedrich MC, Strohm O, Schulz-Menger J, et al.: Contrast media-enhanced magnetic resonance imaging visualizes myocardial changes in the course of viral myocarditis. Circulation 1998, 97:1802-1809.
45. Mahrholdt H, Goedecke C, Wagner A, et al.: Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology. Circulation 2004, 109:1250-1258.
46. Abdel-Aty H, Boye P, Zagrosek A, et al.: Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis: comparison of different approaches. J Am Coll Cardiol 2005, 45:1815-1822.
47. Liu PP, Yan AT: Cardiovascular magnetic resonance for the diagnosis of acute myocarditis: prospects for detecting myocardial inflammation. J Am Coll Cardiol 2005, 45:1823-1825.
48. Wagner A, Schulz-Menger J, Dietz K, Friedrich MG: Long-term follow-up of patients paragraph sign with acute myocarditis by magnetic paragraph sign resonance imaging. MAGMA 2003, 16:17-20.
49. Sasse-Klaassen S, Gerull B, Oechslin E, et al.: Isolated noncompaction of the left ventricular myocardium in the adult is an autosomal dominant disorder in the majority of patients. Am J Med Genet A 2003, 119:162-167.
50. Jenni R, Oechslin E, Schneider J, et al.: Echocardiographic and pathoanatomical characteristics of isolated left ventricular non-compaction: a step towards classification as a distinct cardiomyopathy. Heart 2001, 86:666-671.
51. Oechslin EN, Attenhofer Jost CH, Rojas JR, et al.: Long-term follow-up of 34 adults with isolated left ventricular noncompaction: a distinct cardiomyopathy with poor prognosis. J Am Coll Cardiol 2000, 36:493-500.
52. Petersen SE, Selvanayagam JB, Wiesmann F, et al.: Left ventricular non-compaction: insights from cardiovascular magnetic resonance imaging. J Am Coll Cardiol 2005, 46:101-105.
53. Silverman KJ, Hutchins GM, Bulkley BH: Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis. Circulation 1978, 58:1204-1211.
54. Valantine H, McKenna WJ, Nihoyannopoulos P, et al.: Sarcoidosis: a pattern of clinical and morphological presentation. Br Heart J 1987, 57:256-263.
55. Serra JJ, Monte GU, Mello ES, et al.: Images in cardiovascular medicine. Cardiac sarcoidosis evaluated by delayed-enhanced magnetic resonance imaging. Circulation 2003, 107:e188-e189.
56. Riedy K, Fisher MR, Belic N, Koenigsberg DI: MR imaging of myocardial sarcoidosis. AJR Am J Roentgenol 1988, 151:915-916.
57. Smedema JP, Snoep G, van Kroonenburgh MP, et al.: Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis. J Am Coll Cardiol 2005, 45:1683-1690.
58. Smedema JP, Snoep G, van Kroonenburgh MP, et al.: Cardiac involvement in patients with pulmonary sarcoidosis assessed at two university medical centers in the Netherlands. Chest 2005, 128:30-35.
59. Mady C, Cardoso RH, Barretto AC, et al.: Survival and predictors of survival in patients with congestive heart failure due to Chagas' cardiomyopathy. Circulation 1994, 90:3098-3102.
60. Marin Neto JA, Simoes MV, Sarabanda AV: Chagas' heart disease. Arq Bras Cardiol 1999, 72:247-280.
61. Higuchi ML, Fukasawa S, De Brito T, et al.: Different microcirculatory and interstitial matrix patterns in idiopathic dilated cardiomyopathy and Chagas' disease: a three dimensional confocal microscopy study. Heart 1999, 82:279-285.
62. Higuchi ML, Benvenuti LA, Martins RM, Metzger M: Pathophysiology of the heart in Chagas' disease: current status and new developments. Cardiovasc Res 2003, 60:96-107.
63. Mady C, Ianni BM, Arteaga E, et al.: Relation between interstitial myocardial collagen and the degree of clinical impairment in Chagas' disease. Am J Cardiol 1999, 84:354-356, A9.
64. Rochitte CE, Oliveira PF, Andrade JM, et al.: Myocardial delayed enhancement by MRI in patients with Chagas' disease: a marker of disease severity. J Am Coll Cardiol 2005, 46:1553-1558.
65. Moon J, Coghlan JG, Pennell DJ: Systemic sclerosis involving the heart. Heart 2001, 86:308.
66. Singh JA, Woodard PK, Davila-Roman VC, et al.: Cardiac magnetic resonance imaging abnormalities in systemic lupus erythematosus: a preliminary report. Lupus 2005, 14:137-144.
67. Schmidt WA: Use of imaging studies in the diagnosis of vasculitis. Curr Rheumatol Rep 2004, 6:203-211.
68. Yoshida A, Morozumi K, Suganuma T, et al.: [A case with polyarteritis nodosa associated with acute renal failure and pericardial cyst]. Ryumachi 1989, 29:118-125.
69. Sendoh W, Higami K, Harigai M, et al.: [A case of microscopic polyangiitis with severe cardiac and respiratory muscle involvement]. Ryumachi 1999, 39:757-762.
70. Gallien S, Mahr A, Rety F, et al.: Magnetic resonance imaging of skeletal muscle involvement in limb restricted vasculitis. Ann Rheum Dis 2002, 61:1107-1109.
71. Lightfoot RW, Jr, Michel BA, Bloch DA, et al.: The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa. Arthritis Rheum 1990, 33:1088-1093.